91 related articles for article (PubMed ID: 34057971)
1. Clinical analysis of 125I seed implantation combined with Apatinib in the treatment of locally advanced lung cancer: A case series.
Feng Y; Yang B; Li X
J Pak Med Assoc; 2021 Mar; 71(3):1025-1027. PubMed ID: 34057971
[TBL] [Abstract][Full Text] [Related]
2. To evaluate the efficacy and safety of 125I seed implantation in SCLC as second line therapy.
Cheng G; Wang Y; Dong D; Zhang W; Wang L; Wan Z
Medicine (Baltimore); 2022 Jul; 101(29):e29251. PubMed ID: 35866803
[TBL] [Abstract][Full Text] [Related]
3. A Novel Multimodal Therapy for Anaplastic Thyroid Carcinoma:
Niu Y; Ding Z; Deng X; Guo B; Kang J; Wu B; Fan Y
Front Endocrinol (Lausanne); 2020; 11():207. PubMed ID: 32390940
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of apatinib combined with chemotherapy for advanced non-small cell lung cancer with negative driving genes].
Li YF; Jiang HY; Li Q; Zhu M; Lyu J; Zhao HY
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):775-781. PubMed ID: 31648501
[No Abstract] [Full Text] [Related]
5. [Therapeutic Effect of CT-guided ¹²⁵I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma].
Wang Y; Zhu L; Lin X; He C; An Z; Tang J; Lv W; Hu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):424-428. PubMed ID: 32517444
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of 125I-seed implantation in combination with nimotuzumab therapy for the advanced oral carcinoma: preliminary results.
Meng J; Wang X; Zhuang QW; Gu QP; Zhang J; Li ZP
Eur Rev Med Pharmacol Sci; 2014; 18(21):3304-10. PubMed ID: 25487943
[TBL] [Abstract][Full Text] [Related]
7. Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Liu Z; Ou W; Li N; Wang SY
Thorac Cancer; 2018 Oct; 9(10):1285-1290. PubMed ID: 30126078
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
Zhang H; Yang A; Zhang J
J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
[TBL] [Abstract][Full Text] [Related]
9. [Clinical observation of apatinib mesylate for the treatment of multi-drug resistant advanced breast cancer].
Lü HM; Zhang MW; Niu LM; Zeng HA; Yan M
Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1246-1249. PubMed ID: 29747313
[No Abstract] [Full Text] [Related]
10. [Short-term efficacy of ct-guided radioactive seed 125I implantation on residual or relapsing metastatic lymph nodes in advanced tumor patients after multi-modality treatment].
Jiang Y; Huang ZL; Wu PH; Zhang FJ; Zhao M; Huang JH; Fan WJ; Li CX; Gu YK; Zhang L; Gao F; Li W
Ai Zheng; 2008 Oct; 27(10):1082-7. PubMed ID: 18851789
[TBL] [Abstract][Full Text] [Related]
11. Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Duan JC; Wang ZJ; Lin L; Li JL; Wang Y; Bai H; Hu XS; Liu YT; Hao XZ; Wang HY; Wan R; Wang X; Wang J
Invest New Drugs; 2019 Aug; 37(4):731-737. PubMed ID: 30706337
[TBL] [Abstract][Full Text] [Related]
12. Clinical response to apatinib monotherapy in advanced non-small cell lung cancer.
Xu J; Liu X; Yang S; Zhang X; Shi Y
Asia Pac J Clin Oncol; 2018 Jun; 14(3):264-269. PubMed ID: 29243413
[TBL] [Abstract][Full Text] [Related]
13. [Influence of apatinib and VEGFR2-906T>C polymorphism on clinical outcomes of advanced non-small cell lung cancer patients].
Zhao RH; Zhou YN; Li H; Li R; Zhang WJ; Zong H
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):105-110. PubMed ID: 30669747
[No Abstract] [Full Text] [Related]
14. Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.
Zhang D; Zhang C; Huang J; Guan Y; Guo Q
Thorac Cancer; 2018 Dec; 9(12):1754-1762. PubMed ID: 30338916
[TBL] [Abstract][Full Text] [Related]
15. Radioactive seed implantation and lobaplatin chemotherapy are safe and effective in treating patients with advanced lung cancer.
Li JR; Sun Y; Liu L
Asian Pac J Cancer Prev; 2015; 16(9):4003-6. PubMed ID: 25987076
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.
Wu F; Zhang S; Gao G; Zhao J; Ren S; Zhou C
Cancer Biol Ther; 2018 Mar; 19(3):141-144. PubMed ID: 29261000
[TBL] [Abstract][Full Text] [Related]
17. A phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC.
Huang M; Gong Y; Zhu J; Qin Y; Peng F; Ren L; Ding Z; Liu Y; Cai C; Wang Y; Lu Y
Invest New Drugs; 2020 Apr; 38(2):478-484. PubMed ID: 31231786
[TBL] [Abstract][Full Text] [Related]
18. The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature.
Ding L; Li QJ; You KY; Jiang ZM; Yao HR
Medicine (Baltimore); 2016 May; 95(20):e3598. PubMed ID: 27196461
[TBL] [Abstract][Full Text] [Related]
19. A study on the efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced stage non-small cell lung cancer.
Zhao J; Yu H; Han T; Wang W; Tong W; Zhu X
J BUON; 2019; 24(6):2267-2272. PubMed ID: 31983093
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Ou KP; Li Q; Luo Y; Lyu JJ; Zhou H; Yang Y; Cai YJ; Wang ZJ; Wang X; Qi LQ; Ma F; Xu BH
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):966-971. PubMed ID: 33256310
[No Abstract] [Full Text] [Related]
[Next] [New Search]